267 related articles for article (PubMed ID: 37968959)
21. Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.
Davey DA
Womens Health (Lond); 2012 Mar; 8(2):169-89. PubMed ID: 22375720
[TBL] [Abstract][Full Text] [Related]
22. What is behind the fear of cancer during menopausal hormone therapy in China?
Wang Y; Wang W; Feng Y; Tan Z; Yang X; Peng D; Zhao Y; Dong H; Zheng Q; Zeng X; Zou Y; Sun A
Arch Gynecol Obstet; 2021 Nov; 304(5):1353-1361. PubMed ID: 33813609
[TBL] [Abstract][Full Text] [Related]
23. A review of menopausal hormone therapy: recalibrating the balance of benefit and risk.
Rajan S; Kreatsoulas C
Pol Arch Intern Med; 2019 Apr; 129(4):276-280. PubMed ID: 30608056
[TBL] [Abstract][Full Text] [Related]
24. Management of postmenopausal women: Collège National des Gynécologues et Obstétriciens Français (CNGOF) and Groupe d'Etude sur la Ménopause et le Vieillissement (GEMVi) Clinical Practice Guidelines.
Trémollieres FA; Chabbert-Buffet N; Plu-Bureau G; Rousset-Jablonski C; Lecerf JM; Duclos M; Pouilles JM; Gosset A; Boutet G; Hocke C; Maris E; Hugon-Rodin J; Maitrot-Mantelet L; Robin G; André G; Hamdaoui N; Mathelin C; Lopes P; Graesslin O; Fritel X
Maturitas; 2022 Sep; 163():62-81. PubMed ID: 35717745
[TBL] [Abstract][Full Text] [Related]
25. Prescribing practices of Hormone Therapy for Menopausal females by OBGYN of Pakistan.
Shah N; Tariq H; Khan F; Shah N
Pak J Med Sci; 2023; 39(1):128-132. PubMed ID: 36694745
[TBL] [Abstract][Full Text] [Related]
26. Menopause: Hormones, Lifestyle, and Optimizing Aging.
Minkin MJ
Obstet Gynecol Clin North Am; 2019 Sep; 46(3):501-514. PubMed ID: 31378291
[TBL] [Abstract][Full Text] [Related]
27. Hormone therapy regimens for managing the menopause and premature ovarian insufficiency.
Armeni E; Paschou SA; Goulis DG; Lambrinoudaki I
Best Pract Res Clin Endocrinol Metab; 2021 Dec; 35(6):101561. PubMed ID: 34274232
[TBL] [Abstract][Full Text] [Related]
28. Menopausal Hormone Therapy: a Comprehensive Review.
Lundberg G; Wu P; Wenger N
Curr Atheroscler Rep; 2020 Jun; 22(8):33. PubMed ID: 32556827
[TBL] [Abstract][Full Text] [Related]
29. Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?
Rozenberg S; Al-Daghri N; Aubertin-Leheudre M; Brandi ML; Cano A; Collins P; Cooper C; Genazzani AR; Hillard T; Kanis JA; Kaufman JM; Lambrinoudaki I; Laslop A; McCloskey E; Palacios S; Prieto-Alhambra D; Reginster JY; Rizzoli R; Rosano G; Trémollieres F; Harvey NC
Osteoporos Int; 2020 Dec; 31(12):2271-2286. PubMed ID: 32642851
[TBL] [Abstract][Full Text] [Related]
30. Menopausal hormone therapy (MHT): refining our understanding of MHT research, optimally applying results, and considering the future of MHT.
Anagnostis EA
J Pharm Pract; 2012 Jun; 25(3):324-30. PubMed ID: 22550160
[TBL] [Abstract][Full Text] [Related]
31. An update on menopausal hormone replacement therapy in women and cardiovascular disease.
Valdiviezo C; Lawson S; Ouyang P
Curr Opin Endocrinol Diabetes Obes; 2013 Apr; 20(2):148-55. PubMed ID: 23422240
[TBL] [Abstract][Full Text] [Related]
32. Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease.
Masood DE; Roach EC; Beauregard KG; Khalil RA
Curr Drug Metab; 2010 Oct; 11(8):693-714. PubMed ID: 21189141
[TBL] [Abstract][Full Text] [Related]
33. Hormone therapy and Hypertension in Postmenopausal Women: Results from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
Ferreira-Campos L; Gabrielli L; Almeida MDCC; Aquino EML; Matos SMA; Griep RH; Aras R
Arq Bras Cardiol; 2022 May; 118(5):905-913. PubMed ID: 35613189
[TBL] [Abstract][Full Text] [Related]
34. [Menopausal hormone therapy an cardiovascular risk. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines].
Plu-Bureau G; Mounier-Vehier C
Gynecol Obstet Fertil Senol; 2021 May; 49(5):438-447. PubMed ID: 33757923
[TBL] [Abstract][Full Text] [Related]
35. Impact of Global Consensus Statement on compliance with hormonal therapy for surgical menopause.
Techatraisak K; Rattanachaiyanont M; Tanmahasamut P; Indhavivadhana S; Wongwananuruk T; Jirakittidul P
Climacteric; 2022 Jun; 25(3):300-305. PubMed ID: 34726130
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular health and the menopausal woman: the role of estrogen and when to begin and end hormone treatment.
Naftolin F; Friedenthal J; Nachtigall R; Nachtigall L
F1000Res; 2019; 8():. PubMed ID: 31543950
[TBL] [Abstract][Full Text] [Related]
37. Menopausal hormone therapy: why we should no longer be afraid of the breast cancer risk.
Tan DA; Dayu ARB
Climacteric; 2022 Aug; 25(4):362-368. PubMed ID: 35147073
[TBL] [Abstract][Full Text] [Related]
38. Eligibility criteria for menopausal hormone therapy (MHT): A consortium of scientific societies for the use of MHT in women with medical conditions. Research protocol.
Mendoza N; Ramírez I; De la Viuda E; Vázquez JC; Solá I; Cano A
Maturitas; 2021 Jun; 148():14-17. PubMed ID: 34024346
[TBL] [Abstract][Full Text] [Related]
39. Knowledge of clinical trials regarding hormone therapy and likelihood of prescribing hormone therapy.
Taylor HS; Kagan R; Altomare CJ; Cort S; Bushmakin AG; Abraham L
Menopause; 2017 Jan; 24(1):27-34. PubMed ID: 27575548
[TBL] [Abstract][Full Text] [Related]
40. Vascular effects of estrogenic menopausal hormone therapy.
Reslan OM; Khalil RA
Rev Recent Clin Trials; 2012 Feb; 7(1):47-70. PubMed ID: 21864249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
